Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
antiseptic, antitrust, Bailey, Bees®natural, Box, Caribbean, Check, consulting, denominated, dietary, digestive, dressing, DualDefense, Enlight, entail, expire, extend, extended, fair, Febreze, Greek, head, Healthcare®and, homecare, Infinity, internationaland, Kirsten, Las, leveraging, life, Linda, MacKay, Manjit, Marriner, nasal, Omnicare, onthe, percent, pitcher, Point, productsgenerally, Rendle, Renew, shareholder, Sheet, Singh, slower, straight, talent, threatened, top, TripAdvisor, vertical, voluntarily, weakening, William, yogurt
Filing tables
Filing exhibits
- 10-K Annual report
- 10.3 Amendment No. 1 to the Clorox Company
- 10.13 Amendment No. 2 to the Clorox Company
- 10.22 Amendment No. 1 to the Clorox Company Executive Retirement Plan
- 10.24 Amendment No. 1 to the Clorox Company 2011
- 10.26 Amended and Restated Joint Venture Agreement Dated As of January 31, 2003
- 21 Subsidiaries
- 23 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of the Chief Executive Officer of the Clorox Company
- 31.2 Certification of the Chief Financial Officer of the Clorox Company
- 32 Certification of the Chief Executive Officer and Chief Financial Officer
- 99.1 Management's Discussion and Analysis of Financial Condition
- 99.2 Valuation and Qualifying Accounts and Reserves
- 99.3 Reconciliation of Economic Profit (Unaudited)
- Download Excel data file
- View Excel data file
Related press release
CLX similar filings
Filing view
External links
Exhibit 99.2
VALUATION AND QUALIFYING ACCOUNTS AND RESERVES (Dollars in millions)
Column A | Column B | Column C | Column D | Column E | ||||||||||||||
Additions | Deductions | |||||||||||||||||
Description | Balance at beginning of period | Charged to costs and expenses | Credited to costs and expenses | Credited to other accounts | Balance at end of period | |||||||||||||
Allowance for doubtful accounts | ||||||||||||||||||
Year ended June 30, 2016 | $ | (4 | ) | $ | (1 | ) | $ | - | $ | - | $ | (5 | ) | |||||
Year ended June 30, 2015 | (3 | ) | (1 | ) | - | - | (4 | ) | ||||||||||
Year ended June 30, 2014 | (5 | ) | - | 2 | - | (3 | ) | |||||||||||
LIFO allowance | ||||||||||||||||||
Year ended June 30, 2016 | $ | (34 | ) | $ | (1 | ) | $ | - | $ | 3 | $ | (32 | ) | |||||
Year ended June 30, 2015 | (36 | ) | - | - | 2 | (34 | ) | |||||||||||
Year ended June 30, 2014 | (40 | ) | - | 3 | 1 | (36 | ) | |||||||||||
Valuation allowance on deferred tax assets | ||||||||||||||||||
Year ended June 30, 2016 | $ | (34 | ) | $ | (5 | ) | $ | - | $ | 2 | $ | (37 | ) | |||||
Year ended June 30, 2015 | (51 | ) | (4 | ) | - | 21 | (34 | ) | ||||||||||
Year ended June 30, 2014 | (36 | ) | (25 | ) | - | 10 | (51 | ) |
1